Page last updated: 2024-10-28

hydralazine and Glomerulonephritis, Membranoproliferative

hydralazine has been researched along with Glomerulonephritis, Membranoproliferative in 4 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Glomerulonephritis, Membranoproliferative: Chronic glomerulonephritis characterized histologically by proliferation of MESANGIAL CELLS, increase in the MESANGIAL EXTRACELLULAR MATRIX, and a thickening of the glomerular capillary walls. This may appear as a primary disorder or secondary to other diseases including infections and autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Various subtypes are classified by their abnormal ultrastructures and immune deposits. Hypocomplementemia is a characteristic feature of all types of MPGN.

Research Excerpts

ExcerptRelevanceReference
" After 10 weeks of treatment with benidipine (1, 3, and 5 mg/kg body weight, p."3.70Benidipine, a long-acting calcium-channel blocker, prevents the progression to end-stage renal failure in a rat mesangioproliferative glomerulonephritis. ( Kawachi, H; Nakamura, T; Obata, JE; Onitsuka, M; Shimada, Y; Shimizu, F; Yoshida, Y, 2000)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Villa, L1
Boor, P1
Konieczny, A1
Kunter, U1
van Roeyen, CR1
Denecke, B1
Gan, L1
Neusser, MA1
Cohen, CD1
Eitner, F1
Scholl, T1
Ostendorf, T1
Floege, J1
Tsuboi, Y1
Shankland, SJ1
Grande, JP1
Walker, HJ1
Johnson, RJ1
Dousa, TP1
Nakamura, T2
Obata, J1
Kimura, H1
Ohno, S1
Yoshida, Y2
Kawachi, H2
Shimizu, F2
Obata, JE1
Onitsuka, M1
Shimada, Y1

Other Studies

4 other studies available for hydralazine and Glomerulonephritis, Membranoproliferative

ArticleYear
Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms.
    The Journal of pathology, 2013, Volume: 229, Issue:5

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Benzimidazoles;

2013
Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV.
    The Journal of clinical investigation, 1996, Jul-15, Volume: 98, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Actins; Animals; Blood Pressure; Calcium-Calmodulin-Dependent P

1996
Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
    Kidney international, 1999, Volume: 55, Issue:3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals;

1999
Benidipine, a long-acting calcium-channel blocker, prevents the progression to end-stage renal failure in a rat mesangioproliferative glomerulonephritis.
    Nephron, 2000, Volume: 86, Issue:3

    Topics: Actins; Animals; Blood Pressure; Body Weight; Calcium Channel Blockers; Creatinine; Dihydropyridines

2000